Orthofix Medical Inc. revised earnings guidance for the year ending December 31, 2023. For the period, the company revised net sales to be in the range of $739 million to $744 million from previous guidance range of $752 million to $758 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.89 USD | +0.13% | -0.73% | +10.46% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.46% | 559M | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+2.92% | 41.3B | |
+21.98% | 31.6B | |
+16.29% | 25.03B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- OFIX Stock
- News Orthofix Medical Inc.
- Orthofix Medical Inc. Revises Earnings Guidance for the Year Ending December 31, 2023